Al Hammadi Company For Development and Investment completed the acquisition of a 35% stake in Sudair Pharmaceuticals Company from Gulf Investment Corporation for approximately SAR 120 million.
Al Hammadi Company For Development and Investment (SASE:4007) completed the acquisition of a 35% stake in Sudair Pharmaceuticals Company from Gulf Investment Corporation for approximately SAR 120 million on November 9, 2021. The completion of the due diligence of the financial, legal, administrative and operational conditions. The approvals of all relevant authorities have been secured and the financial valuation has been completed.